Because 5-year patient survival is widely used to predict outcome in RCC, our results clearly indicated that low CHIP expression is associated with poor prognosis, suggesting that CHIP may serve as a molecular prognostic marker for this aggressive disease. The gene discussed is STUB1; the disease is renal cell carcinoma.